These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 26434296

  • 1. Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process.
    Yang L, Sun Z, Zu Y, Zhao C, Sun X, Zhang Z, Zhang L.
    Food Chem; 2012 May 01; 132(1):319-25. PubMed ID: 26434296
    [Abstract] [Full Text] [Related]

  • 2. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.
    Kim JS, Kim MS, Park HJ, Jin SJ, Lee S, Hwang SJ.
    Int J Pharm; 2008 Jul 09; 359(1-2):211-9. PubMed ID: 18501538
    [Abstract] [Full Text] [Related]

  • 3. Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process.
    Anwar M, Ahmad I, Warsi MH, Mohapatra S, Ahmad N, Akhter S, Ali A, Ahmad FJ.
    Eur J Pharm Biopharm; 2015 Oct 09; 96():162-72. PubMed ID: 26241925
    [Abstract] [Full Text] [Related]

  • 4. Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability.
    Qiu L, Zhao X, Zu Y, Zhang Y, Liu Y, Wu W, Li Y.
    Artif Cells Nanomed Biotechnol; 2019 Dec 09; 47(1):610-621. PubMed ID: 30831030
    [Abstract] [Full Text] [Related]

  • 5. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
    Sui X, Wei W, Yang L, Zu Y, Zhao C, Zhang L, Yang F, Zhang Z.
    Int J Pharm; 2012 Feb 28; 423(2):471-9. PubMed ID: 22183131
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preparation and physicochemical properties of vinblastine microparticles by supercritical antisolvent process.
    Zhang X, Zhao X, Zu Y, Chen X, Lu Q, Ma Y, Yang L.
    Int J Mol Sci; 2012 Oct 03; 13(10):12598-607. PubMed ID: 23202916
    [Abstract] [Full Text] [Related]

  • 8. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
    Pi J, Liu Z, Wang H, Gu X, Wang S, Zhang B, Luan H, Zhu Z.
    Curr Drug Deliv; 2016 Oct 03; 13(8):1358-1366. PubMed ID: 26953239
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y, Wu W, Zhao X, Li Y, Wang W, Zhong C, Zhang Y, Zhao X.
    Int J Pharm; 2014 Aug 25; 471(1-2):366-76. PubMed ID: 24882039
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
    Park J, Park HJ, Cho W, Cha KH, Kang YS, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):239-45. PubMed ID: 20599602
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
    Sheth P, Sandhu H, Singhal D, Malick W, Shah N, Kislalioglu MS.
    Curr Drug Deliv; 2012 May 30; 9(3):269-84. PubMed ID: 22283656
    [Abstract] [Full Text] [Related]

  • 15. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
    Ha ES, Kim JS, Baek IH, Yoo JW, Jung Y, Moon HR, Kim MS.
    Drug Des Devel Ther; 2015 May 30; 9():4269-77. PubMed ID: 26345723
    [Abstract] [Full Text] [Related]

  • 16. Preparation and characterization of Tripterygium wilfordii multi-glycoside nanoparticle using supercritical anti-solvent process.
    Chen F, Li T, Li S, Hou K, Liu Z, Li L, Cui G, Zu Y, Yang L.
    Int J Mol Sci; 2014 Feb 17; 15(2):2695-711. PubMed ID: 24549173
    [Abstract] [Full Text] [Related]

  • 17. Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.
    Zhao X, Zu Y, Jiang R, Wang Y, Li Y, Li Q, Zhao D, Zu B, Zhang B, Sun Z, Zhang X.
    Int J Mol Sci; 2011 Feb 17; 12(4):2678-91. PubMed ID: 21731466
    [Abstract] [Full Text] [Related]

  • 18. Production of pure indinavir free base nanoparticles by a supercritical anti-solvent (SAS) method.
    Imperiale JC, Bevilacqua G, Rosa Pde T, Sosnik A.
    Drug Dev Ind Pharm; 2014 Dec 17; 40(12):1607-15. PubMed ID: 24050705
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chitosan modified poly (lactic acid) nanoparticles increased the ursolic acid oral bioavailability.
    Antonio E, Dos Reis Antunes Junior O, Marcano RGDJV, Diedrich C, da Silva Santos J, Machado CS, Khalil NM, Mainardes RM.
    Int J Biol Macromol; 2021 Mar 01; 172():133-142. PubMed ID: 33450338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.